{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:02:53Z","timestamp":1790229773890,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T00:00:00Z","timestamp":1423785600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00259-015-3003-z","type":"journal-article","created":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T14:26:44Z","timestamp":1423751204000},"page":"868-876","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Screening in asymptomatic SDHx mutation carriers: added value of 18F-FDG PET\/CT at initial diagnosis and 1-year follow-up"],"prefix":"10.1007","volume":"42","author":[{"given":"C.","family":"Lepoutre-Lussey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Caramella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bidault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"D\u00e9andreis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Berdelou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Al Ghuzlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hartl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Borget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-P.","family":"Gimenez-Roqueplo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Deschamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lumbroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Guillaud Bataille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schlumberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Baudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Leboulleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,13]]},"reference":[{"issue":"10","key":"3003_CR1","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1210\/jc.2007-0709","volume":"92","author":"L Amar","year":"2007","unstructured":"Amar L, Baudin E, Burnichon N, Peyrard S, Silvera S, Bertherat J, et al. Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. J Clin Endocrinol Metab. 2007;92(10):3822\u20138. doi: 10.1210\/jc.2007-0709 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"3003_CR2","first-page":"5615","volume":"63","author":"AP Gimenez-Roqueplo","year":"2003","unstructured":"Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Crespin M, Nau V, et al. Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas. Cancer Res. 2003;63(17):5615\u201321.","journal-title":"Cancer Res"},{"issue":"3","key":"3003_CR3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2005-1862","volume":"91","author":"DE Benn","year":"2006","unstructured":"Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, et al. Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes. J Clin Endocrinol Metab. 2006;91(3):827\u201336. doi: 10.1210\/jc.2005-1862 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3003_CR4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2796.2009.02111.x","volume":"266","author":"B Pasini","year":"2009","unstructured":"Pasini B, Stratakis CA. SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes. J Intern Med. 2009;266(1):19\u201342. doi: 10.1111\/j.1365-2796.2009.02111.x .","journal-title":"J Intern Med"},{"issue":"5","key":"3003_CR5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2967\/jnumed.108.060731","volume":"50","author":"D Taieb","year":"2009","unstructured":"Taieb D, Sebag F, Barlier A, Tessonnier L, Palazzo FF, Morange I, et al. 18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature? J Nucl Med. 2009;50(5):711\u20137. doi: 10.2967\/jnumed.108.060731 .","journal-title":"J Nucl Med"},{"issue":"16","key":"3003_CR6","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1200\/JCO.2006.09.6297","volume":"25","author":"HJ Timmers","year":"2007","unstructured":"Timmers HJ, Kozupa A, Chen CC, Carrasquillo JA, Ling A, Eisenhofer G, et al. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. J Clin Oncol. 2007;25(16):2262\u20139. doi: 10.1200\/JCO.2006.09.6297 .","journal-title":"J Clin Oncol"},{"issue":"9","key":"3003_CR7","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1210\/jc.2011-0333","volume":"96","author":"KS King","year":"2011","unstructured":"King KS, Chen CC, Alexopoulos DK, Whatley MA, Reynolds JC, Patronas N, et al. Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy. J Clin Endocrinol Metab. 2011;96(9):2779\u201385. doi: 10.1210\/jc.2011-0333 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"3003_CR8","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s00259-012-2087-y","volume":"39","author":"G Treglia","year":"2012","unstructured":"Treglia G, Cocciolillo F, de Waure C, Di Nardo F, Gualano MR, Castaldi P, et al. Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis. Eur J Nucl Med Mol Imaging. 2012;39(7):1144\u201353. doi: 10.1007\/s00259-012-2087-y .","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"3003_CR9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00259-003-1115-3","volume":"30","author":"S Hoegerle","year":"2003","unstructured":"Hoegerle S, Ghanem N, Altehoefer C, Schipper J, Brink I, Moser E, et al. 18F-DOPA positron emission tomography for the detection of glomus tumours. Eur J Nucl Med Mol Imaging. 2003;30(5):689\u201394. doi: 10.1007\/s00259-003-1115-3 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"3003_CR10","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915\u201342. doi: 10.1210\/jc.2014-1498 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"3003_CR11","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00259-012-2215-8","volume":"39","author":"D Taieb","year":"2012","unstructured":"Taieb D, Timmers HJ, Hindie E, Guillet BA, Neumann HP, Walz MK, et al. EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2012;39(12):1977\u201395. doi: 10.1007\/s00259-012-2215-8 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"3003_CR12","doi-asserted-by":"crossref","first-page":"E162","DOI":"10.1210\/jc.2012-2975","volume":"98","author":"AP Gimenez-Roqueplo","year":"2013","unstructured":"Gimenez-Roqueplo AP, Caumont-Prim A, Houzard C, Hignette C, Hernigou A, Halimi P, et al. Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators. J Clin Endocrinol Metab. 2013;98(1):E162\u201373.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"3003_CR13","first-page":"869","volume":"10","author":"PF Plouin","year":"1981","unstructured":"Plouin PF, Degoulet P, Tugaye A, Ducrocq MB, Menard J. Screening for phaeochromocytoma: in which hypertensive patients? A semiological study of 2585 patients, including 11 with phaeochromocytoma (author\u2019s transl). Nouv Presse Med. 1981;10(11):869\u201372.","journal-title":"Nouv Presse Med"},{"issue":"3","key":"3003_CR14","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/clinchem\/38.3.416","volume":"38","author":"V Kairisto","year":"1992","unstructured":"Kairisto V, Koskinen P, Mattila K, Puikkonen J, Virtanen A, Kantola I, et al. Reference intervals for 24-h urinary normetanephrine, metanephrine, and 3-methoxy-4-hydroxymandelic acid in hypertensive patients. Clin Chem. 1992;38(3):416\u201320.","journal-title":"Clin Chem"},{"issue":"9486","key":"3003_CR15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","volume":"366","author":"JW Lenders","year":"2005","unstructured":"Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005;366(9486):665\u201375. doi: 10.1016\/S0140-6736(05)67139-5 .","journal-title":"Lancet"},{"issue":"3","key":"3003_CR16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00259-002-1050-8","volume":"30","author":"DJ Kwekkeboom","year":"2003","unstructured":"Kwekkeboom DJ, Bakker WH, Kam BL, Teunissen JJ, Kooij PP, de Herder WW, et al. Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0),Tyr3]octreotate. Eur J Nucl Med Mol Imaging. 2003;30(3):417\u201322. doi: 10.1007\/s00259-002-1050-8 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"3003_CR17","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jnci\/djs188","volume":"104","author":"HJ Timmers","year":"2012","unstructured":"Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Eisenhofer G, et al. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography. J Natl Cancer Inst. 2012;104(9):700\u20138. doi: 10.1093\/jnci\/djs188 .","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"3003_CR18","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2967\/jnumed.111.098152","volume":"53","author":"D Taieb","year":"2012","unstructured":"Taieb D, Neumann H, Rubello D, Al-Nahhas A, Guillet B, Hindie E. Modern nuclear imaging for paragangliomas: beyond SPECT. J Nucl Med. 2012;53(2):264\u201374. doi: 10.2967\/jnumed.111.098152 .","journal-title":"J Nucl Med"},{"issue":"2","key":"3003_CR19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10689-013-9639-6","volume":"13","author":"KW Jasperson","year":"2014","unstructured":"Jasperson KW, Kohlmann W, Gammon A, Slack H, Buchmann L, Hunt J, et al. Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families. Familial Cancer. 2014;13(2):257\u201365. doi: 10.1007\/s10689-013-9639-6 .","journal-title":"Familial Cancer"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-015-3003-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-015-3003-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-015-3003-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T23:23:58Z","timestamp":1598743438000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-015-3003-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,13]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["3003"],"URL":"https:\/\/doi.org\/10.1007\/s00259-015-3003-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,13]]}}}